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SUMMARY
One of the limitations of many bridging
experiments in neural transplantation is that the
CNS tissues cannot be sutured. Fibrin glue is a
two-component system derived from whole
blood which, when mixed, reproduces the final
stage of blood coagulation and solidifies. Many
experimental studies of humans and animals
show that fibrin glue repair of peripheral nerves
is almost equivalent to microsurgical sutures. In
this study, we attempted to extend its use to
CNS tissues and transplants. Two techniques
were tried: (1) Bilateral parietal knife cuts were
performed by stereotaxic technique in six rats.
Fibrin glue was applied in the right-side cortical
lesion. Immunohistochemistry using antisera to
tyrosine hydroxylase (TH), glial fibrillary acidic
protein (GFAP), laminin and neurof’dament
(NF) was essentially similar between the control
and treatment groups. The immunoreactivity of
each marker revealed no significant differences
between the two groups on days 1, 7 and 30.
There was no difference in terms of gliosis or
microvascular proliferation. (2) Embryonic day
16 fetal locus coeruleus was grafted together
with El6 cortex to the anterior chamber of sym-
pathectomized eyes. In the six eyes of the glue
treatment group, the parietal cortical piece and
the locus coeruleus piece were joined together
before grafting by immersing them in the
solution of fibrin glue. In the eight eyes of the
control group, pieces of parietal cortex and locus
coeruleus were introduced individually and ap-
proximated by gently pressing the cornea. The
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sizes of double grafts showed no significant
difference between groups during six weeks
postgrafting. The immunohistochemical pictures
using antisera against TH, GFAP and laminin
were similar in both groups. Catecholaminergic
fibers from the grafted locus coeruleus were
found bridging over into the parietal cortical
piece in both the control and treatment groups.
There was no significant difference in TH-
positive nerve fiber density between tissue glue-
joined and control double intraocular grafts. In
conclusion, fibrin glue can be used as an ad-
hesive agent in CNS tissues without hampering
the outgrowth of neurites or causing adverse
tissue reactions in fetal or adult nervous tissues.
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INTRODUCTION
In the intensive search for methods to improve
the regenerative capability of CNS tissues, many
different bridging models have been attempted. One
of the limitations of such experiments is that CNS
tissues cannot be sutured. The CNS microvascu-
lature cannot sustain suturing and the fragility ofthe
tissue makes attempts to use stitches hazardous or
useless. One approach uses transplants which may
serve as bridges for regenerating axons across a site
of injury/25/. Alternative methods for bridging by
inserting peripheral nerve pieces, or lodging tissues
into the CNS, or anchoring to the dura matter with
microsutures could provide moderate but not strong
joining.
For peripheral nerve repair, several sutureless
methods have been developed, including fibrin glue
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and laser coaptations /6,8,10-12,14,22,26/. Fibrin
glue, or tissue glue, is a two-component system
derived from whole blood which, when mixed,
reproduces the final stage of blood coagulation to
form a viscous adhesive. This glue is commercially
available and used both clinically and experimentally
in Europe and Japan. It consists of highly concen-
trated human fibrinogen which, after adding apro-
tinin, reacts with the calcium-activated thrombin to
form a sealant that can maintain tissue approxi-
mation. Most ofthe experimental studies on humans
or animals have shown that fibrin glue repair of
peripheral nerves was equivalent to microsurgical
sutures/15,23,27/. Its major advantage over sutures
is that the time required for the procedure is shorter
and the anastomosis is easier to perform, especially
in hard-to-access areas.
In this study, we attempted to extend the use of
fibrin glue to CNS tissues and transplants. First, a
rodent CNS lesion model was used to evaluate any
adverse effect of the glue in lesioned CNS areas.
Next, we used the fibrin glue as an adhesive agent
between two pieces ofintraocular fetal grafts (locus
coeruleus and cerebral cortex) to evaluate its
influence on survival and growth of fetal tissue
grafts. Finally, the intraocular double graft model
allowed us to determine whether nerve fibers could
bridge a layer of fibrin glue at the interface between
two brain tissue areas.
MATERIALS AND METHODS
Fibrin glue
The fibrin glue used for the present study was a
fibrinogen-based compound with double sealant
components (Beriplast(R)P, Behring, Behringwerke
AG, Marburg, Germany). The 1 ml Beriplast(R)P set
contains:
Vial 1" Fibrinogen concentrate consisting of 115-
232 mg dry substance, containing a human plasma
protein fraction with 65-115 mg fibrinogen and a
human plasma protein fraction with a factor XIII
activity of40-80 U.
Vial 2- Aprotinin solution consisting of 1 ml sol-
ution containing 1000 KIU ofbovine lung aprotinin.
Vial 3" Thrombin consisting of 4.9-11.1 mg dry
substance containing a human plasma protein
fraction with a thrombin activity of400-600 IU.
Vial 4" Calcium chloride solution consisting of 2.5
ml solution containing 14.7 mg calcium
chloride.2H20 (40 mmol/1).
Before application, the two sealant elements
were prepared separately by transferring the apro-
tinin solution to the fibrinogen concentrate and
transferring the calcium chloride solution to the
thrombin. To apply the fibrin glue, a tuberculin
syringe was filled with each sealant element. By
pushing the two syringe plungers simultaneously, a
coagulating glue forms between the tips.
Fibrin glue in a CNS lesion model
Adult 150-g female rats (Sprague-Dawley, B&K
Universal, Stockholm) were used to study the effect
of fibrin glue in the CNS lesion model. Under
general halothane anesthesia, the animal was
mounted in a stereotaxic frame. A sharp blade with
a flat cutting edge, 2 mm in length, was clamped
onto the frame. Bilateral parietal craniectomies were
performed to expose 3 x 3 mm
2 areas on both sides.
The central bony ridge over the sagittal sinus was
preserved to impede the liquid flow from one side
to the other. Under stereotaxic guidance, the
centers ofthe craniectomies were identified for cor-
tical incision (AP 1.5, L/R 1.5, V 0 from bregma).
The dura was opened and bilateral cortical incisions
were performed by moving the clamped blade 3 mm
downward (from V 0 to V 3, see Fig. 1). The
contonting vessels on the cortical surface were
cauterized and severed before cutting to prevent
profuse bleeding. Fibrin glue was applied into the
right-side cortical lesion. Care was taken to avoid
any fluid leak to the left side. After the glue hard-
ened, the craniectomies were covered by pieces of
spongostan and the wound closed.
The six rats were grouped into three groups and
sacrificed on days 1, 7 and 28 respectively. The
animals were anesthetized with sodium pentobar-
bital (Mebumal 40 mg/kg i.p.) and perfused via the
ascending aorta with 50 ml calcium-free Tyrode’s
solution followed by 50 ml formalin-picric acid
mixture (4% paraformaldehyde, 0.4% picric acid in
0.16 M phosphate buffer, pH 7.4). Brains were
removed and processed for indirect immunohisto-
chemistry using antibodies against tyrosine hydro-
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Schematic diagram illustrating; the procedures for double intraocular grafts. Pieces of parietal cortex (CC) and locus
coeruleus (LC) were dissected out from the El6 fetal brain. In the treatment group, a cortical piece and a locus
coeruleus piece were joined together by immersing them in the unhardened solution of fibrin glue. The glue-joined
double grafts were introduced into the anterior chambers of sympathectomized eyes. Six weeks later, the grafts were
removed for immunohistochemical examination. C: parietal cortical piece, L: locus coeruleus piece.
xylase (TH), glial fibrillary acidic protein (GFAP),
laminin, and neurofilament protein (NF). Tissues
were examined and photographed using epifluores-
cence microscopy (Nikon-Microphot). Densities of
TH, GFAP, larninin and NF imrntmoreactivities
were semiquantitatively scored on all sections.
Averages from 6-10 sections from a given brain
were then calculated. A semiquantitative scale from
0-5 was used.
Fibrin glue in double intraocular gratis (locus
coeruleus + cortex cerebri)
Young adult 150-g female rats (Sprague-
Dawley, B&K Universal, Stockholm) were used as
hosts to study the effect of fibrin glue in double
intraocular grafts. All eyes were sympathetically
denervated by superior cervical ganglionectomy one
week before transplantation. Fetuses from pregnant
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Immunohistochemistry of lesioned cerebral cortices on days 1, 7 and 30. The histologic pictures with four different
immunoreactive markers were similar between the control (right side) and the glue-treated (left side) cortices. GFAP:
glial fibrillary acidic protein, LAM: laminin, NF: neurofilament protein, TH: tyrosine hydroxylase, a: day 1;b,d and f:
day 7;c,e and g: day 30. Scale bar 500 tm in LAM. Scale bar-- 100 gm in GFAP and NF.
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rats ofthe same strain were used as donors ofCNS
tissue grafts. Pieces of parietal cortex and locus
coeruleus from E16 fetal brains were dissected out.
In the treatment group, the cortical and locus
coeruleus pieces were joined together by immersing
them in the fibrin glue solution. The superfluous
glue around the joined piece was trimmed after the
glue had hardened. After pretreatment of all eyes
with a drop of 1% atropine solution, intraocular
grafting was performed under ether anesthesia.
Grafts were introduced through a tiny opening of
the cornea as previously described/19-21/using a
modified Pasteur pipette. The fibrin glue-treated
combined graft was introduced as a single piece,
while in the control group pieces of parietal cortex
and locus coemleus were introduced individually
and juxtaposed by gentle pressure on the cornea.
After grafting, the volumes of the transplants were
measured at regular intervals by stereomicroscopy.
The graft size was estimated by taking the longest
diameter of the graft multiplied by the diameter
perpendicular to it /4/. Eleven animals were used
which consisted of six eyes in the treated group,
eight eyes in the untreated group and six eyes of
cortico-cortical glue-treated double grafts as
negative controls (see Fig. 1).
The animals were perfused six weeks after
grafting using procedures as stated above and
processed with the same methods for indirect im-
munohistochemistry using antibodies against TH,
GFAP and laminin. Scoring of TH-immunoreactive
nerve fiber density, GFAP-like, and laminin im-
munoreactivities was performed on all sections.
Averages from 6-10 sections from a given graft
were then calculated to generate means of TH-
immunoreactive nerve fiber density, GFAP-like and
laminin immunoreactivity per section. A semiquanti-
tative scale from 0-5 was used.
Statistical analysis
Fibrin glue in CNS lesion model
The data were analyzed by nonparametric Mann-
Whitney tests. Within each group, the data from the
immunoreactivity of glue-applied sides were com-
pared with the data from the corresponding
immunoreactivity of control sides.
Fibrin glue in double intraocular grafts (locus
coeruleus + cortex cerebri)
Graft sizes were analyzed by single-factor
repeated measures ANOVA test. The univariate
analysis was based on repeated measuremems on
the same rats. Number of days after surgery and
number of eyes were treated as within-subject
factors. Rats were grouped within the treatment
groups. The type of treatment was a between-
subject factor. The measurements of TH-immuno-
reactive nerve fiber density, GFAP-like and laminin
immunoreactivity were analyzed by ANOVA.
RESULTS
Fibrin glue in CNS lesion model
The fight parietal cortex cuts which received
fibrin glue were compared with the left parietal
cortices that received lesions only. The patterns of
immunohistochemistry using antisera against TH,
GFAP, laminin and NF were similar between the
control and treatment groups on days 1, 7 and 30
(Fig. 2). There was no difference in the degree of
gliosis or microvascular proliferation. No morpho-
logic evidence of any special tissue reaction could
be found in the treatment group. Using the semi-
quantitative data, none of the immunoreactive
markers revealed in the glue group differed signifi-
cantly from the controls on days 1, 7 or 30 (Fig. 3).
Fibrin glue in double intraocular gratis (locus
coeruleus + cortex cerebri)
Growth ofdouble intraoculargrafts
With or without fibrin glue, joined fetal (El6)
locus coemleus and cortex cerebri double pieces
were grafted to the anterior chamber of the eye of
sympathetically denervated host rats. All but two of
the gratis (in the group of cortico-cortical gratis)
survived well and became vascularized from the
host iris. As shown in Fig. 4, there was no signifi-
cant difference in volume change between the glue-
treated and untreated locus coeruleus plus cortex
cerebri gratis (P 0.25 on day 5, P 0.38 on day
14, and P- 0.52 on day 25, ANOVA).
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Fig. 3: Comparison of the immunoreactivity between glue-
treated and control lesioned cortex with four im-
munohistochemical markers based on 6-10 serial
sections from each brain (n 2 for each group).
The density of neural, glial and vascular elements
with four immunohistochemical stains was similar
in the glue-treated and control lesioned cortex on
days 1, 7 and 30. The fiber density of each section
was graded from 0 to 5. LAM: laminin, GFAP:
glial fibrillary acidic protein, NF: neurofilament
protein, TH: tyrosine hydroxylase.
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Fig. 4" Volume of double intraocular grafts (locus
coeruleus + cortex cerebri, E16) on days 5, 14 and
25. No significant difference in volume change was
noted between the glue-treated and untreated locus
coeruleus plus cortex cerebri grafts (glue-treated
double grafts, n=6; untreated controls, n=8;
ANOVA).
Effects of fibrin glue on TH-positive nerve fiber
density, GFAP and laminin immunoreactivity in
intraocular double grafts
The catecholaminergic fibers in the intraocular
double grafts were examined using TH immuno-
histochemistry. There was no significant difference
in TH-positive nerve fiber density between glue-
joined and untreated locus coeruleus plus cortex
cerebri grafts (Figs. 5, 6; P 0.76, ANOVA).
Comparing the TH-positive fiber density in the
above glue-treated or untreated locus coeruleus
plus cortex cerebri grafts with the glue-treated
cortico-cortical grafts, significant differences were
noted (P 0.017 for the untreated and cortico-
cortical grafts, P-- 0.01 for the glue treated and
cortico-cortical gratis, ANOVA; Fig. 5). Studies of
GFAP and laminin immunoreactivity in the grafts
revealed no obvious differences between the
different treatments (see also Fig. 5).
DISCUSSION
The fact that no morphologic difference could be
fotmd between the fibrin glue-treated and control
lesioned cortex suggests that fibrin glue does not
produce harmful effects in CNS tissue. Gliosis and
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Fig. 5: Immunohistochemistry of double intraocular grafts 37 days postgrafting. The TH-positive nerve fiber density was
similar between glue-joined (upper) and untreated (lower) locus coeruleus plus cortex cerebri grafts. Scale bar 200
tm.
microvascular proliferation did not increase in the
glue-treated lesioned cortices in the early, inter-
mediate or late periods after injury. Studies of TH
and NF immunoreactivity also indicated that neural
components of the CNS tissue are unaltered after
the application of glue. As shown by many authors
/1-3,8-11,13,14,16,22,24,26,28/, fibrin glue pro-
duces no adverse tissue reaction in PNS tissues.
After axotomy, axons can penetrate the glue region
and grow in the distal stumps.
The major controversy concerning the appli-
cation of fibrin glue in peripheral nerve repair is
whether it can replace the conventional microsuture
technique. Studies by several authors/3,9,10,14,22/
have shown that the effect of fibrin glue in nerve
coaptation is comparable to microsutures in tensile
strength, regenerative axonal counts and, although
slower in conduction velocity, electrophysiologic
responses. The advantages of fibrin glue in surgery
are rapidity of application, good hemostasis, easier
stabilization of small gratis and possibility of ana-
stomosis in some difficult anatomical positions
/8,15,22/. The disadvantage ofpossible bacteria and
virus transmission has been resolved by inactivation.
Screening for hepatitis B antibodies since the early
1980s and for AIDS virus antibodies since the
1990s has been done to scrutinize both source
material and the final product/15/. With a relatively
aseptic technique, as presented in this study, infec-
tion is not a problem with the use of fibrin glue in
the CNS tissues.
The vulnerable nature ofthe microvasculature of
CNS tissue, the fragile texture of the parenchyma
and the sophisticated neural networks combine to
make suturing impossible for reparative inter-
vention, qae present htraocular double grafting ex-
periments have demonstrated a possible role for
fibrin glue to act as a CNS adhesive agent to glue
CNS tissues together. The glue-joined fetal double
grafts survived and grew on the iris. Statistical
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Comparison of TH-positive nerve fiber density,
GFAP-like and laminin immunoreactivity between
glue-joined double intraocular grafts (G: locus
coeruleus + cortex cerebri, E16, n=6) and untreated
double intraocular grafts (C: locus coeruleus +
cortex cerebri in HBSS, El6, n=8). Double pieces
of cortex cerebri (Co + Co: cortex cerebri + cortex
cerebri, E16, n=4), joined by fibrin glue, were also
used as negative controls. There is no significant
difference in TH-positive nerve fiber density
between tissue glue-joined and untreated double
intraocular grafts. Significant differences are noted
between the above two groups and the cortico-
cortical grafts (P=0.0165 for C; Co + Co, P=0.0122
for G; Co + Co, ANOVA). No difference is seen in
the density of GFAP-Iike and laminin immuno-
reactivity within the three groups (ANOVA).
analysis showed no significant difference between
the two groups regarding graft volumes. The study
of TH-positive nerve fiber densities of the intra-
ocular double gratis six weeks after grafting
revealed no significant difference between the glue-
treated and the untreated groups. Likewise, GFAP
and laminin immunoreactivity also appeared similar.
Since TH-positive fibers found in the locus
coeruleus plus cortex cerebri gratis could not be
derived from the sympathectomized iris, their
presence in the cortex part of the double graft
proves that a coeruleo-cortical TH-positive pathway
had formed. Clearly, the fibrin glue did not interfere
with the growth ofnerve fibers; nor did it cause any
untoward gliosis or disturbed microcirculation in
the gratis.
Study of the ultrastmcture of fibrin glue with
confocal laser 3D microscopy, li.quid permeation
and turbidity/5/shows that the glue from normal
fibrinogen is composed of straight rod-like fiber
elements which sometimes originate from denser
nodes. The tautness and porosity of the glue net-
works can be altered by changing the concentration
of thrombin and fibrinogen. Thus increasing either
thrombin or fibrinogen concentrations will cause the
glue networks to become tighter and the porosity to
be decreased. The fiber strands also become shorter.
Glue porosity of the network can also be modified
by changing the ionic strengths, coexisting proteins
(e.g. albumin, lipoprotein), dextran, etc.
For the catecholaminergic cells in the locus
coeruleus graft to survive and grow, nutrients and
diffusible factors (such as trophic factors, from
either the iris or the co-grafted cortical piece) must
be able to reach the cells in the graft/18-21/. The
endothelial cells from the iris must also have access
to the graft, otherwise the graft would degenerate
and die. The present study supports the finding that
nutrients and trophic factors can pass through the
fibrin glue networks to reach the graft. It means,
with the present formula, the formed fibrin polymers
create a mesh that will hold two graft pieces
together but also permit the transmission of
essential molecules through its pores. The endo-
thelial cells from the iris can penetrate the fibrin
meshwork around the graft and finally establish the
microvasculature. Likewise, TH-positive fibers from
the locus coeruleus can also penetrate the fibrin glue
in between the two grafts and reach the cortical
piece. The fibrin meshwork is known to be absorbed
by the fibrinolytic system (e.g. plasmin) one week
aer application. The feasibility for the lysis offibrin
glue can also be altered by structural modification
of the extended dimeric multidomained fibrin
molecule (e.g. as shown in the studies ofBlombnck
et al. and Nossel & Kaplan/5,17/, a scheme invol-
ving fibrin I and fibrin II, in which the former is the
result of releasing the fibrinopeptide only. Fibrin II
lacks both fibrinopeptidesA and B and is thought to
be involved in lateral anchoring; as a consequence it
is more resistant to fibrinolysis), presence ofphysio-
logical stabiling factor XIIIa, interactions between
plasminogen, thrombin and fibrin, cross-linked
fibronectin in the tissues, platelets, etc./5,7,17,25/.
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In the anterior chamber ofthe eye, the fibrin glue
is exposed to the chamber fluid, the iris, locus
coeruleus and cortical grail. Since there was no
significant difference in graft growth or final sizes
between glue-treated and control double grafts, it
appears as if the glue coat did not significantly
impair the rate of formation or amount of vascular
connections between host iris and gratis. The lysis
ofthe glue will be affected by numerous factors and
interactions. The timing ofthe penetration of endo-
thelial cells and neurites, in relation to fibrinolysis,
remains to be further analyzed.
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